HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prepubertal anti-Musk positive myasthenia gravis with long remission.

Abstract
Anti-MuSK positive myasthenia gravis (MuSK-MG) is rare prepuberty. We report a female patient with MuSK-MG starting at 3.5years with ptosis as the sole symptom for 2years. A brief period of generalization was followed by complete stable remission for 6years. Prolonged ocular symptoms and long remissions are not features of MuSK-MG, but are often seen in prepubertal onset MG. The patient then presented at age 12 with moderately severe symptoms which were almost confined to oculobulbar muscles and were unresponsive to pyridostigmine. She was dependent on corticosteroids and thymectomy did not seem to be effective. She was later noted to have tongue atrophy after a period without treatment. Our patient thus presented with features seen in many prepubertal patients, but the later course was quite typical of MuSK-MG.
AuthorsOzlem Gungor-Tuncer, Elif Kocasoy Orhan, Vuslat Yilmaz, Yesim Parman, Piraye Oflazer, Guher Saruhan-Direskeneli, Feza Deymeer
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 24 Issue 1 Pg. 36-9 (Jan 2014) ISSN: 1873-2364 [Electronic] England
PMID24074501 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies
  • Receptors, Cholinergic
  • MUSK protein, human
  • Receptor Protein-Tyrosine Kinases
Topics
  • Adolescent
  • Antibodies (blood)
  • Disease Progression
  • Female
  • Humans
  • Myasthenia Gravis (diagnosis, immunology)
  • Receptor Protein-Tyrosine Kinases (immunology)
  • Receptors, Cholinergic (immunology)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: